angiotensinogen and bardoxolone-methyl

angiotensinogen has been researched along with bardoxolone-methyl* in 1 studies

Other Studies

1 other study(ies) available for angiotensinogen and bardoxolone-methyl

ArticleYear
Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2018, Volume: 41, Issue:1

    The aim of this study was to investigate the renoprotective effect of bardoxolone methyl (BM), a nuclear factor erythroid 2-related factor 2 (Nrf2) activator with an antioxidant effect, in a salt-sensitive hypertension model induced by aldosterone (Ald) and salt. Tubulointerstitial damage with urinary liver-type fatty acid-binding protein (L-FABP) was evaluated using human L-FABP chromosomal transgenic (L-FABP

    Topics: Aldosterone; Angiotensinogen; Animals; Blood Pressure; Disease Models, Animal; Fatty Acid-Binding Proteins; Hypertension, Renal; Kidney; Mice; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Renin-Angiotensin System; Sodium Chloride; Up-Regulation

2018